Delivery Order SPE2DB22D1106-SPE2DB25FDJE4

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,557,370,375 Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC is a primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award is for the delivery of 4,566,149,251 units of Epinephrine 0.3 mg auto-injectors on a firm-fixed price basis. The $1,224.96 contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024. The contract has an ultimate completion date of October 21, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 4,566,708,687 units of epinephrine 0.3 mg auto-injectors. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for a firm fixed price of $2,642.89. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of 4,565,069,710 units of epinephrine 0.3 mg auto-injectors over a two-year period ending on July 5, 2024. The contract was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract has a firm fixed-price ceiling of $1,150.20 and was awarded without the use of any set-aside designations. Amerisourcebergen also holds a $999,999,999.00 Indefinite...
This federal contract award is for the delivery of 4,564,260 units of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $2,990.60 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a division of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical for up to $999,999,999.00 through December...
This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract was awarded to the Corporate Office division of AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The firm-fixed-price, delivery order contract is valued at $7,025.86 and has an ultimate completion date of June 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award is for the delivery of 4,566,121,875 units of Epinephrine 0.15 mg Auto-Injectors. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,303.82 Firm Fixed Price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of October 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award is for the delivery of 4,567,197,404 units of epinephrine 0.3 mg auto-injectors. The contract, valued at $23,186.88, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 10, 2025 and is a firm fixed-price delivery order. There is no set-aside designation for this contract. AmerisourceBergen holds a larger...
The U.S. Defense Logistics Agency (DLA) awarded a $1,786.95 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of 4,565,536,694 units of epinephrine 0.3 mg auto-injectors. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical...
This federal contract award is for the delivery of 4,566,929,491 units of epinephrine 0.3 mg auto-injectors over a period ending on January 15, 2025. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,033.50 and is structured as a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen holds a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDJE4
    Delivery Order

This federal contract award is for the delivery of 4,566,250,569 units of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, valued at $7,709.62, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs allow the federal government to efficiently procure essential pharmaceutical and medical supplies to support military healthcare programs, veterans' healthcare, and other federal beneficiaries.

Generated 2/2/25, 12:05 AM